Companies · Biotechnology

Implicit Bioscience Ltd

WOOLLOONGABBA · Biotechnology

Diligence memoA one-page analyst read on Implicit Bioscience Ltd — recommendation, valuation, rhythm, risks.
$702K
Total raised · real
3
Rounds
2.9×
Latest step-up
Top 87%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Fri Sep 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Implicit Bioscience Ltd looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.30× the median modeled value of Pre-Seed Biotechnology companies in 2019–2021 (156 peers) — value vs value, same stage and era.
  • Within the normal band (130% of peer median) for its niche.
Dormant
  • Last raise 6.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Implicit Bioscience Ltd is one of 4293 Biotechnology companies tracked from WOOLLOONGABBA. By capital raised it ranks in the long tail (ahead of 14% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

biotech

As reported in public records reported — not modeled.

US
Jurisdiction
No revenue
Issuer revenue
Rule 506(b)
Reg D exemption
4
Investors (latest)
2019-09-13
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2016-09-05 Raised $210K (real) Modeled valuation $12M (est)$210K$12MPre-Seed2016Pre-Seed · 2017-09-06 Raised $125K (real) Modeled valuation $6.9M (est)$125K$6.9MPre-Seed2017Pre-Seed · 2019-09-13 Raised $367K (real) Modeled valuation $20M (est)$367K$20MPre-Seed2019+$125K+$367KCumulative $702K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$210K · 2016
Pre-Seed extension$125K · 2017
Pre-Seed extension$367K · 2019

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$20.3M
Base estimate est.
$196K
Conservative case
$229.9M
Upside case
$2.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $11.6M · 2016-09-052016Pre-Seed · modeled $6.9M · 2017-09-06Pre-Seed · modeled $20.3M · 2019-09-132019
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
24%
Survival probability
10% low · 44% high
1.86×/yr
Annual markup
2.52×/yr upside case
6.0 yr
Elapsed time used
6.8 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
18 mo
Avg between rounds
$233K/yr
Capital velocity
9.8 yr
On record since
2016
First round
3
Rounds on file
How it compares to the market

Benchmarked against 4293 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$702K
Sector median$7.2M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.9× of median
This company$367K
Sector median$412K
Modeled value — vs sector median (estimate, all stages) 0.3× of median
This company$20.3M
Sector median$64.2M

Raised more than 14% of sector peers (real $). Modeled value above 29% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #65 of 156.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Crimson BioPharm Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)Pinpoint Therapeutics Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)Transplant Logistics & Informatics Llc · Pre-Seed Raised $1.0M · modeled $55.2M (est)RNAissance AG LLC · Pre-Seed Raised $990K · modeled $54.7M (est)Pylum Biosciences, Inc. · Pre-Seed Raised $990K · modeled $54.7M (est)NanoTomer, Inc. · Pre-Seed Raised $950K · modeled $52.4M (est)Morphogenyx Inc · Pre-Seed Raised $4.0M · modeled $51.0M (est)Ntxbio, Llc · Pre-Seed Raised $1.9M · modeled $50.5M (est)Oncospace, Inc. · Pre-Seed Raised $900K · modeled $49.7M (est)Cerflux, Inc. · Pre-Seed Raised $880K · modeled $48.6M (est)KDx Diagnostics, Inc. · Pre-Seed Raised $1.7M · modeled $45.3M (est)Sensorygen, Inc. · Pre-Seed Raised $814K · modeled $44.9M (est)Implicit Bioscience Ltd (this company) Raised $702K · modeled $20.3M (est)Implicit Bioscience Ltd
CompanyStageRaised · realValue · estvs peer med.
Crimson BioPharm Inc.Pre-Seed$1.0M$55.2M3.54×
Pinpoint Therapeutics Inc.Pre-Seed$1.0M$55.2M3.54×
Transplant Logistics & Informatics LlcPre-Seed$1.0M$55.2M3.54×
RNAissance AG LLCPre-Seed$990K$54.7M3.51×
Pylum Biosciences, Inc.Pre-Seed$990K$54.7M3.51×
NanoTomer, Inc.Pre-Seed$950K$52.4M3.36×
Morphogenyx IncPre-Seed$4.0M$51.0M3.27×
Ntxbio, LlcPre-Seed$1.9M$50.5M3.24×
Oncospace, Inc.Pre-Seed$900K$49.7M3.19×
Cerflux, Inc.Pre-Seed$880K$48.6M3.12×
KDx Diagnostics, Inc.Pre-Seed$1.7M$45.3M2.90×
Sensorygen, Inc.Pre-Seed$814K$44.9M2.88×
Implicit Bioscience Ltd this companyPre-Seed$702K$20.3M1.30×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$210K2016-09-05$1.2M$11.6M85%
Pre-Seed$125K2017-09-06$694K$6.9M90%
Pre-Seed$367K2019-09-13$2.0M$20.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$210K2016-09-05
    • First recorded raise — entered as Pre-Seed.
    • 3 investors on this round.
  2. Pre-Seed$125K2017-09-06
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  3. Pre-Seed$367K2019-09-13
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 2.9× larger than the prior — scaling up.
    • 4 investors on this round.
Intelligence
2021 ~Q1
Modeled next raise · ~18mo cadence
$1.1M
Modeled next size est.range $701K$1.7M
2.9×
Last step-up
$233K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Brian William Ziegelaar2016-09
Daniel David Syrdal2016-09
Garry Llewellyn Redlich2016-09
Ian Hector Frazer2017-09
Marion Camac Huntley Koster2019-09
Marion Neil Koster2016-09
Peter Camac Huntley Fry2019-09
Peter Ronald Andrews2016-09
Richard Neil Marsden2016-09
Registry & provenance

Implicit Bioscience Ltd is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1684309
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Perceptive Navigation LLCBiotechnologyPre-Seed$701K$13.8Msame sector · same stage
MK Stem Cell Inc.BiotechnologyPre-Seed$700K$22.1Msame sector · same stage
ImmuVen, Inc.BiotechnologyPre-Seed$710K$14.1Msame sector · same stage
Nexsis Biosciences LLCBiotechnologyPre-Seed$725K$16.1Msame sector · same stage
UberSeq, Inc.BiotechnologyPre-Seed$675K$16.6Msame sector · same stage
Humabiologics, Inc.BiotechnologyPre-Seed$667K$14.9Msame sector · same stage
Vitanova Biomedical, Inc.BiotechnologyPre-Seed$745K$17.9Msame sector · same stage
Leversense, LlcBiotechnologyPre-Seed$659K$22.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Intuitive Biosciences, Inc.BiotechnologySeed$54.3M86%
Trait Biosciences Inc.BiotechnologySeries A$28.5M85%
ARC Medical Inc.BiotechnologySeed$6.3M84%
Protege Biomedical, LLCBiotechnologyPre-Seed$9.7M83%
Advanced Biomedical Technologies Inc.BiotechnologyPre-Seed$5.5M83%
Arc Techtonics, Inc.BiotechnologyPre-Seed$9.4M83%
Arcutis Biotherapeutics, Inc.BiotechnologySeries C$3.9B83%
Biostem TechnologiesBiotechnologySeries A$2.2M82%
Frequently asked
How much funding has Implicit Bioscience Ltd raised?
Implicit Bioscience Ltd has raised approximately $702K in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Implicit Bioscience Ltd's estimated valuation?
Provath's modeled valuation for Implicit Bioscience Ltd is approximately $20.3M (modeled range $196K–$229.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Implicit Bioscience Ltd at?
Implicit Bioscience Ltd's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Fri Sep 13.
What does Implicit Bioscience Ltd do and where is it based?
Implicit Bioscience Ltd operates in the Biotechnology sector, based in WOOLLOONGABBA.
Explore related

See where Implicit Bioscience Ltd sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Implicit Bioscience Ltd, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.